Seqirus readies for $9M expansion project in Holly Springs

Two years after its parent company, CSL, acquired Novartis' global influenza vaccine business for $275 million, Seqirus continues to ramp up production at its Holly Springs site. And now the company is preparing for a $9 million facility expansion.   The expansion is for a new, 15,000-square-foot warehouse to support the company’s growth in manufacturing activity, says Seqirus VP of Operations and Holly Springs Site Head Dr. John Anderson. Seqirus will hold a groundbreaking for the new warehouse…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news